Finding new drug targets in the 21st century

Research output: Contribution to journalReview articlepeer-review

52 Citations (SciVal)

Abstract

The past 30 years have witnessed a steady decline in the number of new drug targets. This review concentrates on the initial process of target identification and argues that current problems have resulted from a decrease in clinical research, an overemphasis on the discovery of new targets through an understanding of the molecular causes of disease and the adoption of cell and animal models that are poor predictors of human disease. To resolve this situation, we argue for increased clinical research and show that an intervention at the physiological level, using drugs to target at the extracellular signalling pathways, will facilitate identification of novel drug targets in the 21st century.

Original languageEnglish
Pages (from-to)1683-1687
Number of pages5
JournalDrug Discovery Today
Volume10
Issue number23-24
DOIs
Publication statusPublished - 31 Dec 2005

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Finding new drug targets in the 21st century'. Together they form a unique fingerprint.

Cite this